SE Life Sciences launches new initiative designed to expand clinical trial diversity see more
National polls show that anywhere from 51 percent to 64 percent of Americans would be willing to be vaccinated against coronavirus.
But the number is far lower for minorities.
Some 49 percent of African Americans and 37 percent of Hispanics say they won’t take the vaccine, according to the Kaiser Family Foundation.
About 39 percent of Blacks cited safety concerns in the poll, while 35 percent cited distrust of the health care system.
That distrust goes back decades to the Tuskegee Experiment, a federal study that allowed syphilis in Black men to go untreated so scientists could observe its progression.
And it affects the way many African Americans view the health system today, with low participation clinical trials - just 5 percent to 7 percent nationally – among the consequences, according to SE Life Sciences, a trade group representing life science companies in the Southeast.
Southeast Life Sciences Launches SE Color, initiate action to encourage minorities to participate in Clinical TrialsSE Color initiates “We Are In” Campaign to encourage minority participation in Clinical Trials see more
On September 9, Southeast Life Sciences announced the formation of SE Color, an organization dedicated to support minority life science entrepreneurship, increase investment in minority-owned life science businesses, and improve minority access to information and clinical opportunities.
The founding advisory board members are Jayne Morgan MD, Clinical Director, Covid Task Force at Piedmont Healthcare, Kornelius Bankston, Managing Partner with techPLUG, and John Newby, Chief Executive Officer for Virginia BIO. As executive director of Southeast Life Sciences, Jason Rupp will staff the organization.
SE Color’s initial effort will focus on increasing the number of minorities in clinical trials. In an article published in Healthcare Tech Outlook, Dr. Morgan notes that, “African Americans make up 13.4 percent of the US population, yet only 5 – 7 percent of clinical trial participants nationally.”
Dr. Morgan further states, “Nearly every advance in medicine today was first evaluated in a clinical trial. Clinical trials offer our best and most forward thinking and can be the gateway to provide earlier access to life saving medicines and therapies years ahead of FDA approval. Equitable participation in clinical trials is therefore a critical call to action in ensuring that medicines, devices, and vaccines that are developed are relevant to all populations.”
Although there are many aspects to facilitate minority recruitment in clinical trials, SE Color will initially focus on education through the “We Are In” campaign. The initial priority will be to share information on clinical trials available throughout the southeast. SE Color will partner with state associations in the region to ensure we have updated information and extend the network.
Southeast Life Sciences recognizes the great need for effort in these areas and though we will only be one part of the solution, we will be part of it. In closing, Bankston adds “I believe the greatest social injustice in modern history is health inequalities which disproportionately impact people of color. We can create more effective therapeutics, applications and medicines for all populations- by addressing the systemic issues in clinical research.”
Southeastern life science organization join forces to promote entire region see more
SCBIO and six additional Southeastern U.S. life science and medtech groups are joining forces to better promote and advocate for the region.
The Southeastern Medical Device Association (SEMDA) on Wednesday announced the formation of an alliance with six individual state medtech and life science advocacy groups: BioAlabama, Bio Florida, Georgia Bio, ncbio, Life Science Tennessee and SCBIO.
“Industry and academic partners simply cannot invest enough in each individual state’s bio advocacy organization — nor travel to each organization’s annual event every single year,” SEMDA executive director Jason Rupp said in a news release.
“But they can come to SEMDA, where the entire region gathers every year bringing their leading investors, academic and industry partners including the best of their young, innovative, investable companies,” Rupp said.
No single state in the Southeastern U.S. can match the medical device and life science industry strength of the nation’s major hubs in California, Minnesota and Massacusetts. But taken together, the region is more competitive, according to industry advocates there.
“We are strongest as a region,” said Russell Allen, president and CEO of Georgia Bio. “If we are to advance medical technologies to improve care, reduce healthcare costs and create new jobs, our state associations must work closely together to connect innovators and share resources.”
The announcement was made at the inaugural 2018 SEMDA Medtech Conference May 2-4 in Greenville, S.C.
Dr. Denise Hines, Joe Lee, Other Top National Speakers Named for SEMDA’s 2018 Southeastern Medtech Conference in Greenville, SCSEMDA Medtech 2018 is coming to Greenville, SC May 2-4. see more
Conference Registration Surging for Initial Appearance in Greenville, SC as Southeastern medtech industry continues rapid scale up
Greenville, SC – April 17, 2018 -- The Southeastern Medical Device Association (SEMDA) -- a non-profit trade association focused on making the Southeast a world-class region for medical technology, device, and diagnostic companies – has announced an initial group of featured speakers for the 2018 SEMDA Medtech Conference May 2-4, 2018.
For the first time ever, the annual Southeastern showcase of who’s who and what is happening in medtech will convene in South Carolina, with the Hyatt Regency Greenville serving as headquarters hotel.
Among the featured speakers announced today that have committed to present at the conference are Joe Lee, Executive Director of Life Sciences for JP Morgan; Andy Fish, Chief Strategy Officer of AdvaMed; and Denise Hines, North American Chair of the Health Information & Management Systems Society and current CEO of eHealth Services Group. Also speaking will be Lee Burnes, Vice President of Global Research & Development at Halyard Health; and Jim Stefansic, Chief Executive Officer of Raiven Healthcare.
Additional featured speakers are expected to be named shortly, and companies engaged in presenting to industry executives in the PitchRounds program, co-sponsored by SCRA, SCBIO and Eversheds Sutherland, will be announced within the week. PitchRounds is a highly targeted event for both start-ups and “Seed” companies as well as later-stage (Series A or later) organizations to present ideas, innovations and products to panels of institutional investors, regulatory leaders, venture capital directors, IP experts and others in structured sessions. Selected participants receive individual feedback on their presentations and compete for $10,000 in top prize money.
“The South Carolina medtech industry has been a strong supporter of SEMDA for many years and is growing at one of the fastest rates in the country, so we are excited to tap into the growth and excitement in the industry by bringing this preeminent event to the Palmetto State for the first time,” said Jason Rupp, Executive Director of SEMDA. “Most importantly, we are thrilled to unveil members of a stellar group of industry experts who will be presenting to members drawn from across the Southeastern United States and to industry attendees from across North America.”
The SEMDA conference typically attracts more than 400 executives in medtech and life sciences from throughout the United States and has become a must-attend for the medtech community. Registration is currently surging, noted Mr. Rupp, and a full house of medtech industry leaders is again expected. Persons interested in attending can review the agenda, speakers and registration details online at http://www.semda.net.
Joe Lee, who will keynote Day 2 of the conference, is Executive Director of Life Sciences for JP Morgan and leads the Middle Market Banking coverage of life science companies across the Southeast. Well-known and respected in life science industry circles, Mr. Lee will discuss key opportunity areas for growth in the Southeast and provide rapid-growth companies with counsel on how to prepare their organizations for success in the competitive space.
Andrew Fish is Chief Strategy Officer of AdvaMed, the leading trade association advancing medical technology in the U.S. and around the world. As chief strategy officer, Mr. Fish leads the association’s strategic planning, oversees AdvaMed's global, regulatory, and payment departments, and coordinates the development and operations of AdvaMed’s membership divisions and sectors.
Dr. Denise Hines is current Chair of the North America Board of the Health Information & Management Systems Society (HIMSS), and is actively involved in HIMSS’ Women in Health IT initiatives that promote diversity and recognition. She is CEO of eHealth Services Group and serves as Executive Director of Georgia’s statewide health information exchange (HIE).
Lee Burnes is Vice President of Global R&D for Halyard Health where the organization is focused on development of products, technologies and solutions that prevent infection, eliminate pain and speed recovery. Prior to joining Halyard, Lee successfully led numerous R&D organizations at Covidien.
Jim Stefansic serves as President and CEO of Raiven Healthcare, a provider of healthcare artificial intelligence and data analytics solutions. An accomplished entrepreneur, Jim has years of experience launching and growing numerous healthcare technology businesses. He previously was co-founder and COO of Pathfinder Therapeutics, Inc., where he helped bring industry-leading image-guided surgical products to market.
“These presenters and others we will announce shortly demonstrates that SEMDA has evolved into a truly regional organization that embraces and represents the collective of medtech startups, universities, corporate organizations, investment resources and capabilities across the southeastern United States,” Mr. Rupp said. “The conference provides a great opportunity to interact with other companies, investors, customers, partners, and specialized service providers.”
# # #
The Southeastern Medical Device Association (SEMDA) is a regional non-profit trade association that supports and promotes medical device and medical device data system (MDDS) companies in the Southeast. Created in 2004, the association provides unique educational resources to accelerate device development and achieve commercial success with access to funding, education, and networking opportunities for medical device companies, inventors, physicians, investors, tech transfer offices, universities, sponsors, and service providers interested in growing the medical device industry in the Southeast.